Additionally, it is unclear if described decreases in XPC expression are in cancer cells alone or found in other cells within the tumor microenvironment, such as fibroblasts, in which XPC inhibition could be expected to decrease the tumor promoting cytokine IL-6 (72). The gene discussed is IL6; the disease is neoplasm.